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Nutritional and pharmacological stimuli can dramati-
cally alter the cellular phenotypes in white adipose
tissue (WAT). Utilizing genetic lineage tracing tech-
niques, we demonstrate that brown adipocytes
(BA) that are induced by b3-adrenergic receptor acti-
vation in abdominal WAT arise from the proliferation
and differentiation of cells expressing platelet-
derived growth factor receptor alpha (PDGFRa),
CD34, and Sca-1 (PDGFRa+ cells). PDGFRa+ cells
have a unique morphology in which extended
processes contact multiple cells in the tissue micro-
environment. Surprisingly, these cells also give rise
to white adipocytes (WA) that can comprise up to
25% of total fat cells in abdominal fat pads following
8 weeks of high-fat feeding. Isolated PDGFRa+ cells
differentiated into both BA andWA in vitro and gener-
ated WA after transplantation in vivo. The identifica-
tion of PDGFRa+ cells as bipotential adipocyte
progenitors will enable further investigation of mech-
anisms that promote therapeutic cellular remodeling
in adult WAT.
INTRODUCTION
Adipose tissue is a dynamic organ, whose metabolic pheno-
type and cellular composition can vary dramatically in
response to pharmacological, nutritional, and environmental
stimuli (Cinti, 2005). For example, cold exposure or pharmaco-
logical activation of b3-adrenergic receptors (ADRB3) induces
the appearance of brown adipocytes (BA) in typical white
adipose tissue (WAT) depots (Cousin et al., 1992; Young
et al., 1984). In addition, high-fat feeding expands adipose
tissue mass in part by recruiting white adipocytes (WA) from
progenitor cells (Gray and Vidal-Puig, 2007; Joe et al., 2009).
A substantial body of evidence indicates that adipose tissue
dysfunction contributes importantly to the adverse outcomes
associated with obesity (Galic et al., 2010) and that recruitment
of beneficial cellular phenotypes might offer a means of thera-
peutic intervention (Sethi and Vidal-Puig, 2007). Thus, an480 Cell Metabolism 15, 480–491, April 4, 2012 ª2012 Elsevier Inc.important task to achieving this end is the in vivo identification
of BA and WA progenitors that are involved in adult WAT
cellular plasticity.
Most previous approaches to identifying BA and WA progen-
itors have relied on ‘‘prospective analyses’’ in which cells are
isolated from enzymatically dissociated tissues by fluores-
cence-activated cell sorting (FACS) and are demonstrated to
have adipogenic potential in vitro and in vivo following
transplantation (Rodeheffer et al., 2008; Schulz et al., 2011;
Vegiopoulos et al., 2010). Although these experiments clearly
established the existence of cells with adipogenic potential,
only in vivo lineage tracing can establish which of these popu-
lations in fact become BA or WA in response to nutritional and
pharmacological stimuli (Kretzschmar and Watt, 2012). In this
regard, tracing studies have established that BA in conven-
tional brown adipose depots, such as the interscapular pad,
arise from myogenic Myf5+ progenitors, but those induced to
appear in WAT do not (Seale et al., 2008). In addition, Tang
and colleagues (Tang et al., 2008), traced developmental WA
progenitors in typical WAT to cells residing in the vascular
mural compartment that express peroxisome proliferator-acti-
vated receptor gamma (PPARg) and the pericyte markers
platelet-derived growth factor receptor beta (PDGFRb) and
smooth muscle actin (SMA). Perhaps not surprisingly, these
cells proliferate and differentiate into WA following treatment
of mice with chemical PPARg agonists (Tang et al., 2011) that
are used for the treatment of adult-onset diabetes. It is not
known whether these cells contribute to brown adipogenesis
during adrenergic stimulation or white adipogenesis induced
by high-fat feeding.
Taking advantage of conditions in which most BA induced by
ADRB3 stimulation were derived from proliferating cells, we
developed a strategy to identify inducible BA (iBA) progenitors.
Fate tracing of proliferating progenitors tagged with thymidine
analogs identified platelet-derived growth factor receptor alpha
(PDGFRa) as a likely marker of the BA progenitors. Lineage
tracing using constitutive and inducible reporter systems
demonstrated that iBA in WAT were derived from a population
of stellate-like cells that express PDGFRa, Sca-1, and CD34.
Surprisingly, in the absence of ADRB3 stimulation, stellate
PDGFRa progenitors differentiated into WA in adult WAT, and
this phenomenon was dramatically promoted by high-fat
feeding. These results define a population of bipotential progen-
itors that contribute to cellular remodeling in adult WAT.
Figure 1. iBA in WAT Are Derived from Proliferating Cells during b3-Adrenergic Stimulation
(A) Cumulative BrdU labeling during continuous CL316,243 (CL) treatment.
(B) Immunoblot analysis of WAT from 129S1 mice treated with CL. Equal amounts of proteins were run, and blots sequentially probed for UCP1 and loading
controls.
(C–E) BrdU incorporation analysis in adipose tissue 7 days after CL treatment. CL induced greater proliferation in eWAT versus iWAT (mean ± SEM, n = 4 per
group, p = 0.006) (C). Representative images of BrdU+, UCP1+ cells in tissue paraffin sections with arrows indicating double-positive multilocular adipocytes are
shown in (D). Proliferation of iBA in iWAT and eWAT is shown in (E). Values are the percentage of BrdU+, UCP1+ to total UCP1+ cells. (Mean ± SEM, n = 4 per group,
p < 0.0001.).
(F) EdU flash-labeling. 129S1 mice were infused with CL up to 3 days and injected with EdU 2 hr before analysis.
(G) CL significantly increased mitotic indices of both eWAT and iWAT (p < 0.0001), and the effect was significantly greater in eWAT versus iWAT (ANOVA
interaction p = 0.0033, posttest ***p < 0.001) (mean ± SEM, n = 3–4 per group).
Cell Metabolism
In Vivo Brown and White Adipocyte ProgenitorsRESULTS
Recruitment of BA in WAT by ADRB3 Stimulation
Involves Depot-Specific Mechanisms
Previous experiments demonstrated that a significant fraction
of BA induced in WAT by ADRB3 stimulation can be derived
de novo from proliferating progenitors (Granneman et al.,
2005). In the present experiments, we investigated the contribu-
tion of proliferation to BA induction using a low dose of the
ADRB3 agonist CL316,243 (CL) that resulted in greater levels
of proliferation without signs of lipolysis-induced inflammation
(Granneman et al., 2005; Li et al., 2005; Mottillo et al., 2007).
Control and CL-treated mice were coinfused with 5-bromo-20-
deoxyuridine (BrdU) to cumulatively label proliferating cells
(Figures 1A and S1A), and the mitotic index and the proportion
of BrdU labeling in UCP1+ adipocytes were determined in
epididymal (eWAT), inguinal (iWAT), and interscapular (BAT) fat
pads.
ADRB3 activation induced expression of UCP1 in iWAT within
3 days of treatment, whereas pronounced expression of UCP1
(i.e., detected by immunoblot) was observed in eWAT only afterC7 days (Figure 1B). Under control conditions, virtually no UCP1+
cells were detected in WAT, and <0.4% of nucleated cells incor-
porated BrdU over 7 days in WAT or BAT (Figure S1B). CL treat-
ment increased the mitotic index of cells in both eWAT and
iWAT; however, the mitogenic effect of CL was far greater in
eWAT (Figure 1C). The vast majority of UCP1+ cells observed
in eWAT were positive for BrdU (82.2% ± 3.6% of total UCP1+
cells, Figures 1D and 1E), indicating most iBA in eWAT came
from newly born cells. In contrast, only 5.8% ± 3.0% of UCP1+
cells in iWAT were BrdU+ (Figure 1E). These results indicate
that most UCP1+ cells in eWAT are derived from the induction
of brown adipogenesis from progenitors, whereas the upregula-
tion of UCP1 expression in iWAT involves the conversion or
‘‘transdifferentiation’’ of existing WA into a BA phenotype.
Cellular expression levels of UCP1 were similar among UCP1+
multilocular cells in interscapular BAT, iWAT, and eWAT (Figures
1D, S1C, and S1D). CL had no effect on cell proliferation in BAT,
further supporting differences in the origin of constitutive and
inducible BA. Flash-labeling (2 hr exposure) demonstrated that
CL treatment produced pronounced proliferation that peaked
after 3 days of treatment (Figures 1F and 1G).ell Metabolism 15, 480–491, April 4, 2012 ª2012 Elsevier Inc. 481
Figure 2. Fate Tracing of Proliferating Cells Identifies PDGFRa+ Cells as Potential iBA Progenitors
(A) Representative images of eWAT paraffin sections triple-stained for PDGFRa, PLIN1, and EdU onD1, D2, or D3 of CL treatment. Note that images of a given day
are the samemicroscopic field. Top row shows merge of PDGFRa (red) and EdU (green), while bottom row is merge of PLIN1 (red) and EdU (green). Arrows mark
PDGFRa+ EdU+ cells. Arrow heads mark PLIN1+ EdU+ cells. Nuclei were counterstained with DAPI (blue). Triple-stained images demonstrate that PLIN1 and
PDGFRa expression are mutually exclusive.
(B and C) Quantification of PDGFRa+, EdU+ cells or PLIN1+, EdU+ cells in eWAT paraffin sections (mean ± SEM, n = 3–4 per group). Nearly all proliferating cells in
eWAT express either PDGFRa or PLIN1. The percentage of PLIN1+, EdU+ cells increased over time (C, p = 0.0004) as the percentage of PDGFRa+, Edu+ cells
declined (B, p = 0.002).
(D) Fate tracing of cells labeled with EdU on the third day of CL treatment. 129S1 mice were infused with CL, injected with EdU on D3, and analyzed at indicated
time points.
(E) Representative images of eWAT paraffin sections triple-stained for PDGFRa, PLIN1, and EdU at 2 hr, 12 hr, and 24 hr after EdU injection. Top row showsmerge
of PDGFRa (red) and EdU (green), while bottom row is merge of PLIN1 (red) and EdU (green) of the same field. Arrows mark PDGFRa+, EdU+ cells. Arrow heads
mark PLIN1+, EdU+ cells.
(F) Low-magnification fields of eWAT paraffin sections double-stained for EdU (green) and UCP1 (red) at 24 hr after EdU injection.
(G and H) Proportion of each cell type is expressed as percentage of the total EdU+ cells (mean ± SEM, n = 3–4 per group). PDGFRa expression declined
(p = 0.0002) as PLIN1 expression appeared (p = 0.0001) in EdU-labeled cells. By 24 hr, 85% of EdU+ cells expressed UCP1. Bars = 20 mm.
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as Potential iBA Progenitors
We next sought to characterize the phenotype of cells that were
flash-labeled with EdU after 1, 2, and 3 days of CL treatment
(Figures 2A–2C). As detailed below, proliferating cells did not482 Cell Metabolism 15, 480–491, April 4, 2012 ª2012 Elsevier Inc.express detectable PDGFRb, SMA, or CD24, which are
found in WA progenitors (Rodeheffer et al., 2008; Tang et al.,
2008). The recent report identifying PDGFRa as a marker of
ectopic adipocyte progenitors in skeletal muscle (Joe et al.,
2010; Uezumi et al., 2010) prompted us to examine PDGFRa
Figure 3. Phenotypic and Morphological Characteristics of PDGFRa+ Cells
(A) Immunostaining of PDGFRa+ cells in eWAT whole mount from control 129S1 mice. Stellate morphology of PDGFRa+ cells (red). Each cell had multiple
processes, some up to 50 mm long, and contacted multiple cells, including adipocytes (lipid+, green). PDGFRa+ cells were often in close apposition to IB4+
vasculature (green), but did not constitute themural compartment, indicated by extended processes (arrows). PDGFRa+ cells were negative for SMA and PPARg.
Nuclei were counterstained with DAPI. Bars = 20 mm.
(B) FACS analysis of cell surface marker expression of PDGFRa+ cells. PDGFRa+ cells were uniformly positive for CD34 and Sca-1, but negative for IB4, CD24,
and PDGFRb. The percentage of double-positive cells are indicated on the flow profile (mean ± SEM, n = 3 independent analyses).
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cells in control WAT. We found nearly 80% of actively dividing
cells expressed PDGFRa after the first day of CL treatment
(Figures 2A and 2B). Unexpectedly, a terminal adipocyte differ-
entiation marker, Perilipin1 (PLIN1), was also expressed in
numerous EdU flash-labeled (i.e., 2 hr exposure) cells, especially
after 3 days of CL treatment. EdU+ adipocytes were small
(<10 mm) and contained small lipid droplets, indicating that newly
differentiating adipocytes candivide (Pilgrim, 1971). (Wehavenot
observed cell division in mature, unilocular adipocytes.) Interest-
ingly, >90% of EdU+ cells expressed PDGFRa or PLIN1 (Figures
2B and 2C), but none expressed both markers at the same time
(Figure 2A, compare upper and lower panels). Importantly, the
frequency of PDGFRa expression in EdU+ cells declined as
PLIN1 expression increased, suggesting that PDGFRa+ progen-
itors might become PLIN1+ iBA over the course of CL treatment
(Figures 2B and 2C). Because the population of PDGFRa+ cells
did not change during CL treatment (Figure S2A), it appears
that some newly divided cells replenish the progenitor pool while
others downregulated PDGFRa and differentiated into BA.
To trace the fates of proliferating cells in eWAT, mice were
given single injections of EdU on the third day of CL infusion,
when proliferation is maximal, and the phenotypic characteris-
tics of EdU-labeled cells were evaluated over time (Figure 2D).
Over the 24 hr period after flash-labeling, the number of EdU+
cells expressing PDGFRa progressively decreased as the
number of EdU+ cells expressing PLIN1 increased (Figures 2E–
2H), indicating that proliferating cells lose PDGFRa expression
as they become fat cells. By 24 hr after EdU injection, most
proliferating cells were multilocular and expressed PLIN1
(88.1% ± 4.3%) and UCP1 (85.4% ± 3.8%) (Figure 2H).CWe performed an additional experiment to trace a relatively
pure population of PDGFRa+ cells by labeling cells with EdU
on day 1 (Figure S2D). As expected, 88.8% ± 1.8% of EdU+ cells
expressed PDGFRa, and 2 days later most EdU+ cells tagged
became multilocular brown adipocytes that expressed PPARg,
PLIN1, and UCP1. Interestingly, 16.0% ± 1.6% of EdU+ cells
labeled on day 1 retained PDGFRa expression 2 days later
(Figures S2E and S2G), indicating that PDGFRa+ cells undergo
self-renewal as well as adipogenic differentiation. To test
whether undifferentiated (PDGFRa+, PLIN1) and newly differen-
tiated (PDGFRa, PLIN1+) cells can undergo multiple divisions,
CL-treated mice were injected with EdU on the first day of CL
treatment and again with BrdU 1 day later (Figure S2C). Data
from this dual pulse labeling indicated that 48.0% ± 11.3% of
EdU+ PLIN1+ cells (that divided on day 1) were marked by
BrdU on day 2 (Figure S2J), demonstrating that a significant
number of iBA progenitors divided more than once.
Phenotypic and Morphological Characteristics
of PDGFRa+ Progenitors
Confocal imaging of whole-mount adipose tissue revealed the
unique morphology of PDGFRa+ cells. These cells extended
multiple thin cytoplasmic processes (50 mm in length) that
were in close proximity to stromal cells, adipocytes, and capil-
laries (Figure 3A and Movie S1). Although sometimes coursing
along capillaries, the processes of PDGFRa+ cells extended
into the interstitial space (Figure 3A, arrows). PDGFRa+ cells
were also observed on large-diameter blood vessels; however,
these cells were not labeled by thymidine analogs and thus do
not contribute directly to brown adipogenesis induced by CL.
As mentioned earlier, WA progenitors have been identified asell Metabolism 15, 480–491, April 4, 2012 ª2012 Elsevier Inc. 483
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et al., 2008). In contrast, adipose tissue PDGFRa+ cells labeled
immunochemically or genetically (below) were negative for
SMA and PPARg (Figure 3A). Furthermore, unlike pericytes/
adipocyte progenitors, stromal PDGFRa+ cells were larger and
did not share a collagen IV basement membrane with endothelial
cells, as do PDGFRb+ pericytes (Figures S3A and S3B). Analysis
of eWAT stromal cells by FACS demonstrated that PDGFRa+
cells are a subpopulation of cells expressing the stem cell
markers CD34 and Sca-1 (Figure 3B), but we did not detect
significant coexpression with WA progenitor markers CD24
and PDGFRb or with the endothelial cell marker isolectin IB4.
Lineage Tracing Reveals that PDGFRa+ Cells Become
BA during b-Adrenergic Stimulation
To provide conclusive information on the fate of the PDGFRa-ex-
pressing progenitors, we performed in vivo lineage tracing with
two different PDGFRa reporter lines. In one series of experi-
ments, we crossed Cre-responsive (stop codon-floxed) reporter
mice (Madisen et al., 2010) with mice expressing tamoxifen-
inducible CreERT2 under the control of PDGFRa promoter
(Rivers et al., 2008) (Figure 4A). In this system, treatment of
mice with tamoxifen induces expression of tdTomato in
PDGFRa+ cells via Cre-mediated recombination. Because the
induction is permanent, reporter expression remains in all of
the cells descending from the originally marked cells.
tdTomato was not observed in the absence of tamoxifen treat-
ment. Tamoxifen induced strong tdTomato fluorescence with
high efficiency in adipose tissues (PDGFRa+ tdTomato+/
PDGFRa+ = 57.5% ± 5% in iWAT and 50.4% ± 3% in eWAT).
Strong native fluorescence (tdTomato) was uniformly distributed
throughout the cells and allowed 3D visualization of their fine
structures in whole-mount tissues. Consistent with immunos-
taining analysis, tdTomato-labeled cells were often located in
the perivascular region and displayed long, thin processes that
contacted adjacent adipocytes and vasculature (Figure 4C and
Movie S2). Prior to CL treatment, all tdTomato+ cells expressed
PDGFRa and CD34 (Figure 4D), but not the developmental WA
progenitor markers PPARg, PDGFRb, or SMA (Figure 4C).
After 7 days of CL treatment, nearly half of the tdTomato-ex-
pressing cells had multilocular morphology and expressed BA
markers PPARg, PLIN1, and UCP1 (Figures 4E–4H). PPARg
and PLIN1 are early markers of BA differentiation that were often
observed in actively dividing cells. While half of tdTomato+ cells
were BrdU+ (Figure 4H), over 90% of tdTomato+ multilocular
adipocytes were BrdU+. Conversely, 45% ± 14% of UCP1+ cells
in eWAT expressed the tdTomato reporter. Given a reporter
recombination efficiency of 50%, we estimate that approxi-
mately 90% of iBA in eWAT were derived from proliferating
PDGFRa+ cells. As expected from EdU tagging experiments,
multilocular tdTomato+ cells lacked expression of PDGFRa (Fig-
ure 4E, arrowheads), whereas stellate progenitors remained
PDGFRa+ (Figure 4E, arrows). Furthermore, the percentage of
tdTomato+ cells that became PLIN1+ adipocytes was 3-fold
higher in eWAT compared to iWAT (not shown). Finally, we iso-
lated tdTomato+ cells from control mice and mice treated with
CL for 7 days by FACS and examined adipogenic gene expres-
sion (Figure 4I). Consistent with immunochemical analyses, CL
treatment dramatically upregulated expression of brown adipo-484 Cell Metabolism 15, 480–491, April 4, 2012 ª2012 Elsevier Inc.cyte markers Ucp1, Elovl3, Dio2, and Cidea. It should be noted
that this analysis likely underestimates the effect of CL since
floating adipocytes were not recovered.
In a second series of experiments, chromatin-targeted
H2BeGFP that was transgenically expressed from the PDGFRa
locus (Figure S4A) was used to trace the fate of PDGFRa+ cells
in the absence of ongoing PDGFRa expression. Immunohisto-
chemical analysis confirmed that prior to CL treatment, all
GFP+ cells expressed PDGFRa and CD34, but not PPARg,
PDGFRb, or IB4 (Figures S4B and S4C). As expected, nearly
80% of cells induced to divide after 1 day of CL were GFP+,
and few of these cells expressed PPARg (Figure S4E). However,
by day 3, 55.3% ± 6.3% of EdU+ cells that divided on day 1
expressed both GFP and PPARg (Figures S4E and S4F). Multi-
locular GFP+ cells expressed PLIN1 and UCP1, which were tar-
geted to lipid droplets and mitochondria, respectively (Figures
S4F and S4G). It is important to note that these cells were nega-
tive for PDGFRa protein and the presence of GFP reflected prior,
not current, expression of PDGFRa. Collectively, lineage tracing
with two independent genetic marking systems clearly demon-
strates that PDGFRa+ cells are BA progenitors within WAT.
Clonal Analysis Demonstrates that PDGFRa+ Cells
Have BA and WA Potential
PDGFRa+ progenitors were isolated by single-cell FACS, and
individual colonies were expanded and subjected to adipo-
cyte-differentiating conditions (Uezumi et al., 2010) used for
establishing adipogenic potential in prospective analyses.
Numerous adipocytes were found in more than 70% of clones
derived from single cells (Figure 5A). The potential of PDGFRa+
to form colonies and differentiate into adipocytes was similar
to that reported for muscle-derived PDGFRa+ cells (Joe et al.,
2010; Uezumi et al., 2010). Interestingly, the adipogenic potential
of clones derived from eWAT, iWAT, and interscapular BAT did
not differ significantly (Fisher’s exact test, p > 0.95). All adipo-
genic colonies from eWAT contained UCP1+ BA to varying
degrees, ranging from 7% to 71% of total adipocytes (n = 29
clones). Figure 5B shows a representative colony stained for lipid
and UCP1.
We also tested the in vitro differentiation potential of PDGFRa+
cells that were isolated from WAT of Pdgfra-H2BeGFP mice by
FACS (Figure 5C). Each fraction was expanded under growth
conditions and then exposed to insulin for 7 days to induce adi-
pogenesis. Expanded PDGFRa+ cells retained expression of
Pdgfra,Cd34, Sca1 (Ly6a), andCd29 (Itgb1), but did not express
Pdgfrb or Cd24 (Figure 5D). Although both populations formed
adipocytes after insulin treatment, the adipogenic potential of
the PDGFRa+ population was much higher than that of the
PDGFRa population based on the proportion of lipid-laden cells
in culture (Figure 5E) and the expression of terminal adipocyte
differentiation markers (Figure 5F). This adipogenic induction
did not require IBMX and dexamethasone, which are typically
used to trigger preadipocyte differentiation. We also evaluated
whether differentiated cultures could be induced to express BA
markers in response to b-adrenergic stimulation. b-adrenergic
stimulation strongly induced expression of peroxisome prolifera-
tor-activated receptor g coactivator 1a (Pgc1a), Ucp1, and Dio2
(Figure 5G), confirming brown adipogenic potential of PDGFRa+
cells in vitro.
Figure 4. PDGFRa-Expressing Progenitors Become BA during b3-Adrenergic Stimulation
(A) Schematic diagram of the inducible Pdgfra-CreERT2/R26-LSL-tdTomato reporter system.
(B) Procedure of reporter induction and lineage tracing of tdTomato-labeled cells. Efficiency and specificity of reporter induction were analyzed 7 days after the
first tamoxifen dose. Adipose tissue was analyzed before (D0) or 7 days (D7) after CL and BrdU infusion.
(C and D) Characterization of reporter+ cells prior to CL treatment. Labeled cells were often found near blood vessels (IB4+) and had long processes that
appeared to contact stromal cells and adipocytes (LipidTox+). tdTomato+ cells were negative for PPARg, PDGFRb, and SMA, but uniformly positive for PDGFRa
and CD34.
(E–G) Characterization of reporter+ cells following 7 days of CL treatment. tdTomato+ multilocular adipocytes (arrowheads) lacked expression of PDGFRa,
whereas stellate-like progenitors (arrows) remained PDGFRa+. tdTomato+ multilocular cells coexpressed PPARg and UCP1 and contained PLIN1+ lipid droplets.
Incorporation of BrdU of tdTomato+ multilocular adipocytes indicates that iBA came from proliferating cells. Low magnification images are shown of eWAT
paraffin sections double stained for tdTomato and PLIIN1 (F) or UCP1 (G). Arrowsmark double-positive cells. At right is amagnified view of the boxed region from
left. Bars = 20 mm.
(H) Distribution of markers in tdTomato+ cells (mean ± SEM, n = 3 per group). All tdTomato+ cells expressed PDGFRa and none expressed PPARg on day 0.
By day 7, 47.3% ± 1.5% of tdTomato+ cells retained expression of PDGFRa while 52.9% ± 7.2% of tdTomato+ cells expressed PPARg (Fisher’s exact
test, p < 0.0001). In addition, PLIN1 (38.7% ± 10.6%) and UCP1 (21.5% ± 4.4%) expression and BrdU incorporation (49.3% ± 13.2%) were detected in
tdTomato+ cells.
(I) Quantitative PCR analysis of BA marker expression in Pdgfra-tdTomato-tagged cells isolated by FACS, expressed relative to mRNA levels of D7. BA markers
were significantly upregulated in tdTomato+ cells after 7 days of CL treatment. (Mean ± SEM, n = 4–5, Plin1: p = 0.016, fatty acid-binding protein 4 [Fabp4]:
p = 0.057, Ucp1: p = 0.008, Elovl3: p = 0.029, Dio2: p = 0.033, Cidea: p = 0.011.)
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Figure 5. PDGFRa-Expressing Progenitors Are White and Brown Adipogenic In Vitro
(A and B) Adipogenic potential of clones (nR 39) derived from FACS-isolated PDGFRa+ single cells. Representative images of adipogenic clones double-stained
for UCP1 and lipid (LipidTox) are shown in (B). Lipid (left) and UCP1 (middle) fluorescent images were merged with phase contrast, and lipid and UCP1 images
were merged with DAPI-counterstained images. Bottom row is a magnified view of the boxed regions from top row. All adipogenic clones contained UCP1+ and
UCP1 adipocytes, demonstrating WA and BA bipotentiality of PDGFRa+ progenitors. Bar = 100 mm.
(C) FACS analysis of H2BeGFP+ (PDGFRa+) cells from WAT.
(D) Quantitative RT-PCR analysis of surface marker expression after 5–7 days of culture in growth medium (means ± SEM, n = 4).
(E) Representative images of PDGFRa+ or PDGFRa cells cultured in the presence of insulin (1 mg/ml) for 7 days. Boron-dipyrromethene (BODIPY, red) staining
indicates higher insulin-stimulated adipogenesis in PDGFRa+ fractions.
(F and G) Quantitative RT-PCR analysis on adipocyte gene expression. Expression of adipocyte-specific markers, normalized to that of PDGFRa+ cells, is shown
in (F). PDGFRa+ cells were significantly more responsive to insulin-induced adipogenesis, compared to PDGFRa cells (means ± SEM, n = 4, Pparg: p = 0.002,
Fabp4: p = 0.004, Plin1: p = 0.012, and lipoprotein lipase (Lpl): p = 0.0003). Expression of brown adipocyte-specific markers, normalized to levels induced by
isoproterenol, is shown in (G). Differentiated PDGFRa+ populations (cultured in the presence of insulin for 7 days) were treated with vehicle (CTL) or isoproterenol
(ISO, 10 mM) for 4 hr before analysis (means ± SEM, n = 4, Ucp1: p = 0.0009, Pgc1a: p = 0.0003, Dio2: p = 0.0095, Ppara: p = 0.120). Experiments were repeated
four times.
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Adipogenesis during High-Fat Feeding
In vitro analysis indicated that PDGFRa+ cells may becomeBA or
WA, depending on the method of induction and level of adren-
ergic stimulation. To test whether PDGFRa+ cells contribute to
white adipogenesis in vivo, PDGFRa+ cells were tagged with
tdTomato, and mice were maintained on chow or were fed
high-fat diet (HFD) for 8 weeks. tdTomato-labeled adipocytes486 Cell Metabolism 15, 480–491, April 4, 2012 ª2012 Elsevier Inc.were found in isolated small clusters throughout control eWAT
pads (Figure 6A). HFD greatly increased the number tdTomato+
adipocytes, which were found in large, extensive clusters
throughout eWAT pads (Figure 6A). Immunofluorescence anal-
ysis of paraffin sections confirmed extensive coexpression of
PLIN1 in tdTomato+ adipocytes (Figure 6B). Furthermore, all
tdTomato+ adipocytes of controls andHFDmicewere unilocular,
and none expressed UCP1 (not shown). HFD greatly increased
Figure 6. PDGFRa+ Progenitors Contribute to Adult White Adipogenesis under Control Conditions and during Adipose Tissue Expansion
Induced by High-Fat Feeding
(A) Representative images of tdTomato+ cells in eWAT whole mount from control and HFD mice. tdTomato fluorescent images are merged with phase contrast
(left) along with a magnified region illustrating tdTomato+ adipocyte clusters (right).
(B) Representative images of eWAT paraffin sections double-stained for tdTomato and PLIN1. Images demonstrate abundance of tdTomato+ adipocytes in eWAT
from HFD mice.
(C) Effect of HFD on the weight of eWAT pads (left) and adipocyte triglyceride content (right).
(D) The density of tdTomato+ adipocytes in these pads of mice on chow and HFD. The number of tdTomato+ cells was estimated in eWAT pads, and proportion of
tdTomato+ adipocytes is expressed as percentage of the total adipocytes. Circles indicate individual animals and the horizontal lines represent groupmeans. Size
bars = 100 mm.
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expansion was mediated largely by adipocyte hypertrophy (Fig-
ure 6C). Although there was considerable overlap in adipocyte
cellularity between groups (not shown, p = 0.22), there was no
overlap between chow and HFD mice in the number or density
of adipocytes derived from PDGFRa+ cells (Figure 6D, p =
0.0002). Indeed, we estimate that up to 25% of total eWAT
adipocytes were derived from PDGFRa+ cells after 8 weeks of
HFD versus <1.8% in controls.
Transplanted FACS-Purified PDGFRa+ Cells from WAT
Form WA In Vivo
As a final demonstration of the white adipogenic potential
of PDGFRa+ progentiors, we transplanted PDGFRa+ andCPDGFRa cells, purified by FACS from WAT of GFP transgenic
mice, into syngenic mice (C57B/6) and determined the efficiency
of transplantation 4 weeks later (Figure 7). Matrigel transplants
contain a mixture of donor- and recipient-derived fat cells
(Kawaguchi et al., 1998). The donor contribution, calculated as
the fraction of GFP+ adipocytes over total adipocytes in the
Matrigel transplant, was 20-fold higher in transplants of
PDGFRa+ cells (Figure 7F). Although multilocular adipocytes
were detected, none were UCP1+ BA. Moreover, CL treatment
4 weeks after transplantation failed to induce UCP1 expression
in transplants (data not shown), implying a crucial role of the
endogenous microenvironment in progenitor fate determination.
This result further substantiates that PDGFRa+ cells are bipoten-
tial progenitors that can give rise to WA or BA.ell Metabolism 15, 480–491, April 4, 2012 ª2012 Elsevier Inc. 487
Figure 7. In Vivo Adipogenic Potential of FACS-Purified PDGFRa-Expressing Progenitors
(A) FACS analysis of PDGFRa+ cells from WAT of GFP transgenic mice. The x axis indicates PE intensity (PDGFRa expression). Histogram with dashed line
represents the negative control for PDGFRa staining.
(B) Representative low-magnification images of engrafted PDGFRa+ or PDGFRa cells in Matrigel 4 weeks after transplantation. Bars = 50 mm. GFP (green)
fluorescent images were merged with phase contrast (left), Nile red fluorescence (middle, red), or PLIN1 immunofluorescence (right, red). Images demonstrate
abundance of GFP+ adipocytes in PDGFRa+ transplants by native fluorescence in whole-mount tissue (left and middle) and by immunostaining on paraffin
sections (right). Nuclei were counterstained with DAPI.
(C) Quantitative analysis of GFP+ adipocytes. Donor contribution is the percentage of total adipocytes (Nile red+, PPARg+) from the transplant that were donor
derived (GFP+). Values are means ± range for two independent experiments (p < 0.0001, Fisher’s exact test).
(D and E) High-magnification images of Nile red (left, red) and PPARg (right, red) in whole-mount tissues. Bars = 20 mm.
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Growing evidence indicates that disruption of the interrelated
metabolic, endocrine, and immune functions of adipose tissue,
as occurs during overnutrition, contributes to risk of diabetes,
cardiovascular disease, and certain cancers (Khandekar et al.,
2011). The fact that the cellular composition andmetabolic char-
acter of adipose tissue is responsive to nutritional and pharma-
cologic stimuli (Prins and O’Rahilly, 1997) raises the possibility
that adipose tissue plasticity might be targeted for therapeutic
benefit (Sun et al., 2011). Nonetheless, the nature of progenitors
involved in cellular plasticity of adult WAT in vivo is poorly
understood.
One potential therapeutic avenue that has been suggested is
the expansion of metabolically desirable BA in typical WAT
depots (Tseng et al., 2010; Whittle et al., 2011). We previously
reported that at least 20% of multilocular cells in WAT are gener-
ated by cell proliferation over 7 days following a standard dose of
CL (Granneman et al., 2005). In the present work, we reduced
that dose by 75% in order to diminish fatty acid-induced inflam-488 Cell Metabolism 15, 480–491, April 4, 2012 ª2012 Elsevier Inc.mation (Granneman et al., 2005; Mottillo et al., 2007) and found
substantially greater proliferation of iBA progenitors in abdom-
inal WAT. Interestingly, nearly all BA in abdominal WAT were
derived de novo, whereas the vast majority of BA in inguinal fat
involved conversion of existing WA to a BA phenotype, as previ-
ously proposed (Barbatelli et al., 2010; Cinti, 2009). The imme-
diate progenitors of ‘‘convertible’’ adipocytes in inguinal fat
have not been established by tracing techniques, and it is
unclear whether these differ from ‘‘inducible’’ BA in perigonadal
fat or whether differences in tissue microenvironment play an
important role. Regardless, the rapid proliferation and differenti-
ation of BA progenitors in eWAT provided a strategy to identify
and trace their fate in vivo.
We established that nearly all proliferating cells marked with
EdU after 1 day of CL treatment expressed PDGFRa, but not
previously identified markers of developmental WA progenitors
(discussed further below). Three days later, 65% of tagged cells
expressed UCP1, strongly indicating that BA are derived from
proliferating PDGFRa+ cells. This conclusion was confirmed
using two independent transgenic models that traced the fate
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inducible Cre-mediated recombination was used to permanently
tag PDGFRa+ cells immediately prior to CL treatment. These
experiments provided compelling data demonstrating that
ADRB3 stimulation triggers proliferation and differentiation of
PDGFRa+ cells into BA. The second model used H2BeGFP
expressed from the Pdgfra locus to tag cells with high fidelity
and efficiency with a durable marker. Results with this model
confirmed that PPARg+ PLIN1+ multilocular adipocytes are
derived from proliferating cells that lose expression of PDGFRa
as they differentiate into adipocytes.
PDGFRa+ progenitors represent a subpopulation of stromal
cells expressing the common stem cell markers CD34 and
Sca-1. ADRB3 stimulation triggered proliferation of PDGFRa+
cells by the first day of CL treatment and generated a transiently
amplifying population of progenitors. Although the vast majority
of proliferating cells differentiated into BA, a significant fraction
of daughter cells retained stem cell characteristics, and the
progenitor population remained stable over time. Surprisingly,
by the third day of CL treatment, the majority of proliferating cells
were small, newly differentiated cells with PLIN1+ lipid droplets.
Clearly, growth arrest is not required for differentiation of BA
in vivo.
PDGFRa+ progenitors also had WA potential in vitro and
contributed to white adipogenesis in adults under control condi-
tions and during high-fat feeding. In chow-fed mice, tdTomato+
adipocytes were rarely observed as single cells, but rather
were nearly always found in clusters, indicating that both WA
progenitors likely undergo proliferation prior to differentiation,
as do BA progenitors. HFD greatly promoted adipocyte hyper-
plasia from PDGFRa+ progenitors. By considering steady-state
cellularity alone, one might incorrectly conclude that HFD
expands fat mass solely by expanding the triglyceride content
of existing fat cells. However, inducible tagging, which allows
assessment of cellular dynamics, clearly demonstrates signifi-
cant adipocyte recruitment and possible turnover.
Several groups have isolated distinct cell populations from
adipose tissues and muscle that have the potential to form white
or brown adipocytes in vitro and in vivo, following transplantation
(Joe et al., 2010; Petrovic et al., 2010; Rodeheffer et al., 2008;
Schulz et al., 2011; Uezumi et al., 2010). Although this ‘‘prospec-
tive’’ approach clearly identifies cells with adipogenic potential,
only lineage tracing can establish which of these potential
progenitors, if any, become BA or WA during WAT remodeling
in vivo. We believe that PDGFRa+ progenitors described here
can be distinguished from WA stem cells described by Rode-
heffer et al. (Rodeheffer et al., 2008) on the basis of tissue abun-
dance and CD24 expression. It seems likely that PDGFRa+ cells
are a subpopulation of the Sca-1+ cells that were recently shown
to be capable of brown adipogenesis (Schulz et al., 2011).
However, in contrast to our experiments, cells isolated by these
investigators required ex vivo treatment with bone morphogen-
7 for BA differentiation, and these cells were absent in eWAT.
Tang and colleagues (Tang et al., 2008) utilized lineage tracing
techniques to identify direct precursors of WA as cells within
themural compartment that express PPARg and several pericyte
markers. In contrast to those WA progenitors, the PDGFRa+ BA
progenitors identified here were negative for PPARg, SMA, and
PDGFRb and clearly resided outside of the mural compartment.CPDGFRa+ progenitors are found in numerous tissues where
they appear to be involved in cellular repair and restoration
(Andrae et al., 2008; Hoch and Soriano, 2003). For example,
PDGFRa+ cells may differentiate into fibroblasts or adipocytes
in damaged muscle (Joe et al., 2010; Uezumi et al., 2010),
depending on the nature of the damage. PDGFRa+ progenitors
comprise 5% of cells in brain and contribute to oligodendrocyte
formation in adults and CNS remyelination following injury
(Zawadzka et al., 2010). Interestingly, the three-dimensional
morphology of brain and adipose PDGFRa+ progenitors is strik-
ingly similar: both extendmultiple cellular processes that contact
numerous cell types and give the impression of being capable of
monitoring themicroenvironment (Richardson et al., 2011). In the
case of adipose tissue, we suggest that PDGFRa+ cells are adult
stem cells that sense metabolic stress or adipogenic signals and
contribute to tissue remodeling and restoration. We anticipate
that the in vivo identification of PDGFRa+ as bipotential adipo-
cyte progenitors in adult WATwill provide insights into themech-
anisms that promote WAT remodeling for therapeutic benefit.
EXPERIMENTAL PROCEDURES
Mice
129S1/SvImJ (129S1; stock no. 002448), C57BL/6J (C57B/6; stock no.
000664), B6.129S4-Pdgfratm11(EGFP)Sor/J (Pdgfra-H2BeGFP; stock no.
007669), C57BL/6-Tg(CAG-EGFP)1Osb/J (GFP; stock no. 003291), and
B6.Cg-Gt(ROSA)26Sortm9(CAG-tdTomato)Hze/J (Madisen et al., 2010) (R26-LSL-
tdTomato; stock no. 007909) were purchased from the Jackson Laboratory.
Pdgfra-CreERT2 mice (Rivers et al., 2008) were obtained fromWilliam Richard-
son (University College London). All animal protocols were approved by the
Institutional Animal Care and Use Committee at Wayne State University.
For continuous b-adrenergic stimulation, mice were infused with CL
(0.75 nmol/hr) by mini osmotic pumps (ALZET) for up to 7 days. For BrdU
cumulative labeling, BrdU (Sigma, 20 mg/hr) were infused with CL for 7 days
by mini osmotic pumps. For EdU flash-labeling, mice were injected with
EdU (Invitrogen, 2 nmol/mouse, i.p.) at indicated times described in the text.
For dual pulse-labeling, mice were injected first with EdU and then BrdU
(2 mg/mouse) with 24 hr intervals. BrdU was detected by immunostaining,
as described below. EdU was detected according to the instructions of the
manufacturer (Invitrogen). Intestines from each individual mouse were used
as positive controls for EdU or BrdU detection.
Cre recombination in double transgenic mice (Pdgfra-CreERT2/R26-LSL-
tdTomato) was induced by administering tamoxifen dissolved in sunflower
oil (Sigma, 300 mg/kg, P.O.) on each of 5 consecutive days. CL treatment or
HFD were started 1 week after the first dose of tamoxifen. We included
no-tamoxifen controls to confirm that tdTomato expression is undetectable
in the double transgenic mice gavaged with vehicle (oil only). For the HFD
experiments, 60% fat diet (Research Diets, D12492) was introduced at
5–6 weeks of age and continued for 8 weeks.
Tissue Processing and Immunostaining
Tissues were fixed with 10% formalin overnight at 4C, embedded in paraffin,
and cut into 5 mm-thick sections. For whole mounts, fixed tissues were minced
into %2 mm3 pieces. Immunostaining was performed in either paraffin
sections or whole-mount tissue. Samples were preincubated with permeabili-
zation buffer (0.5% Triton X-100 in PBS) and blocking buffer (5% normal
donkey serum in PBS) for 30 min at room temperature and then incubated
sequentially with primary antibody and secondary antibody, all in blocking
buffer. For BrdU detection, paraffin sections were incubated in 2 N HCl for
45min at 37Cbefore permeabilization. After washing with TPBS (0.1%Tween
20), samples were counterstained with DAPI. Slides were coverslipped in
mounting medium (Dako) and examined by fluorescence microscopy.
Species-matched IgG were used as nonspecific controls.
Total adipocyte numbers in eWAT of mice from the HFD study were
calculated as previously described (Hirsch and Gallian, 1968). Briefly, eWATell Metabolism 15, 480–491, April 4, 2012 ª2012 Elsevier Inc. 489
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images of fixed whole mounts using IPlab software, andmean triglyceride (TG)
mass/adipocyte was calculated as 0.4790/106 3 (3 3 s2 3 mean diameter +
[mean diameter]3). Tissue adipocyte cellularity was determined by dividing
tissue TG content by mean fat cell TG mass. Total tdTomato+ adipocytes
were estimated by extrapolation from the number of cells counted in 10 mg
samples.
WAT SVC and Adipocyte Fractionation
Adipose tissues were washed with PBS, minced, and digested with type II
collagenase (2 mg/ml) in KRBB containing 10 mM HEPES (pH 7.4), and 3%
BSA for 1 hr at 37C. Preparations were passed through a 300 mm mesh
and centrifuged at 500 g for 5 min. Floating adipocytes were collected by
aspiration. Pellets containing the stromal vascular (SV) fractionwere incubated
in red blood cell lysis buffer for 5 min at room temperature, passed through
a 40 mm mesh, and then collected by centrifugation at 500 g for 5 min.
The resultant cell preparations were subjected to immunostaining or flow
cytometry.
Flow Cytometry
For FACS analysis, SV fractions from mouse WAT were resuspended in PBS
plus 2% FBS and 0.5 mM EDTA. Cells were incubated with anti-PDGFRa
(CD140a)-PE and other cell surface marker antibodies for 30 min on ice (see
Supplemental Experimental Procedures for sources and concentrations). Anti-
bodies used were anti-CD34-FITC, anti-Sca1-FITC, anti-CD24-FITC, and IB4-
FITC. For PDGFRb staining, SV fractions from Pdgfra-H2BeGFP mice were
incubated with anti-PDGFRb (CD140b)-PE. This strategy was adopted
because the signals for allophycocyanin-conjugated anti-PDGFRb antibodies
were too low to permit quantification with available anti-PDGFRa antibodies.
Species-matched IgG were used as nonspecific controls (Figure S3B). For
cell sorting, SV cells from GFP mice were labeled with anti-PDGFRa (biotiny-
lated, R&D Systems) and streptavidin-PE sequentially. SV fractions from
Pdgfra-reporter mouse WAT (Pdgfra-H2BeGFP or Pdgfra-CreERT2/R26-
tdTomato) were sorted based on native fluorescence (GFP or tdTomato,
respectively).
Cell Culture of FACS-Isolated Cells
SVCs of adipose tissue from Pdgfra-H2BeGFP mice were FACS-sorted by
GFP fluorescence. Single cells were sorted into individual wells of 96-well
plates coated with Matrigel. Single colonies were confirmed at <16 cell stage,
and proliferating clones were maintained for 2 weeks in growth medium
(DMEM supplemented with 20% FBS and 2.5 ng/ml bFGF). Adipogenic differ-
entiation was induced by incubating cells in DMEM with 20% FBS, 1 mg/ml
insulin, 0.25 mM dexamethasone, and 0.5 mM IBMX. Three days later, clones
were placed in DMEMwith 20%FBS and 1 mg/ml insulin for 4 days. Aminimum
of 39 colonies derived from the PDGFRa+ single cells from each fat depot was
analyzed for adipogenic differentiation. Colonies were stained for lipid (Lipid-
Tox) to identify adipocytes and for UCP1 to identify BA.
In a separate experiment, FACS-purified GFP+ and GFP cells were
collected by centrifugation at 500 g for 5 min, seeded at a density of 2.5 3
104/well in 48-well plates, and expanded in growth medium. For adipogenic
differentiation, confluent cells were exposed for 7 days to insulin (1 mg/ml) in
DMEM supplemented with 10% FBS. For the acute b-adrenergic stimulation,
cells were treated with isoproterenol (10 mM) for 4 hr.
Transplantation of FACS-Isolated Cells
FACS-purified PDGFRa+ and PDGFRa cells from GFP mice were collected
by centrifugation at 500 g for 5 min. For each fraction, 105 cells were immedi-
ately mixed with Matrigel (150 ml) and injected subcutaneously into the
hindlimbs of syngenic recipient mice (C57B/6) that were anesthetized with
Avertin. Entire transplantswere collected after 4weeks and stained for PPARg,
PLIN1, or lipid (Nile red). Donor cell-derived adipogenesis in transplants was
calculated by the number of GFP+ adipocytes (PPARg+ nile red+) divided by
the number of total adipocytes.
Microscopy
Fluorescence and bright-field microscopy was performed using an Olympus
IX-81 microscope equipped with a spinning disc confocal unit and 40X490 Cell Metabolism 15, 480–491, April 4, 2012 ª2012 Elsevier Inc.(0.9NA) and 60X (1.2NA) water immersion objectives, using standard excitation
and emission filters (Semrock) for visualizing DAPI, FITC (Alexa Fluor 488), Cy3
(Alexa Fluor 555, 594, Nile Red), and Cy5 (Alexa Fluor 647, LipidTox) as
described (Granneman et al., 2009). Confocal z stacks were captured for
whole-mount tissue by imaging up to 39 optical sections at 0.4–1 mm incre-
ments. Raw data of single optical sections (paraffin sections) or confocal z
stacks (whole mount tissues) were processed using IPlabs software (Scana-
lytics, BD Biosciences) and Adobe Photoshop.
Statistical Analysis
Statistical analyses were performed with GraphPad Prism 5. Data are pre-
sented as mean ± SEM. Statistical significance between two groups was
determined by unpaired t test or Mann-Whitney test, as appropriate. Compar-
ison among groups was performed using one-way ANOVA or two-way
ANOVA, with Bonferroni posttests to determine the relevant p values. Fisher’s
exact test was used to evaluate differences in cell distributions.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one table, Supplemental
Experimental Procedures, and two movies and can be found with this article
online at doi:10.1016/j.cmet.2012.03.009.
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